LLY - Financial Reports List - Eli Lilly and Company - IntrinsicAlpha

Eli Lilly and Company LLY

Healthcare - Drug Manufacturers - General - NYSE - US

$ 920.63

1.71 %

$ 873 B

Market Cap

78.75

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	44.68%	101.39%	67.27%
Annual Report	FY	10-K	2024-12-31	32.00%	102.08%	24.92%
Quarterly Report	Q3	8-K	2024-09-30	20.43%	1790.42%	884.55%
Quarterly Report	Q2	8-K	2024-06-30	35.98%	68.27%	102.48%
Quarterly Report	Q1	8-K	2024-03-31	25.98%	66.77%	75.33%
Quarterly Report	Q4	8-K	2023-12-31	28.10%	13.01%	67.62%
Annual Report	FY	10-K	2023-12-31	19.56%	-16.08%	44.87%
Quarterly Report	Q3	8-K	2023-09-30	36.84%	-3.95%	-77.91%
Quarterly Report	Q2	8-K	2023-06-30	28.11%	85.11%	22.77%
Quarterly Report	Q1	8-K	2023-03-31	-10.88%	-29.32%	-37.86%

1